Raymond James Financial’s Xilio Therapeutics XLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.8K Sell
18,761
-15,200
-45% -$10.3K ﹤0.01% 5734
2025
Q1
$24.6K Sell
33,961
-16,125
-32% -$11.7K ﹤0.01% 4642
2024
Q4
$47.8K Buy
+50,086
New +$47.8K ﹤0.01% 4564